Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ANZEMET DIN 02231379

Status: Cancelled Post Market
Holder: SANOFI-AVENTIS CANADA INC
Molecule: DOLASETRON MESYLATE

Health Canada record

Active ingredient(s)DOLASETRON MESYLATE 100 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCA04AA04 DOLASETRON
Original market date15-Aug-1997
Current status date21-Apr-2014
SourceHealth Canada DPD

Establishment licence of the holder

sanofi-aventis Canada Inc. — licence 101470, currently licensed, last inspection rating C (2026-02-17).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DOLASETRON MESYLATE

DINProductCompanyFormStrengthStatus
02231378ANZEMETSANOFI-AVENTIS CANADA INCTabletDOLASETRON MESYLATE 50 MGCancelled Post Market
02231380ANZEMET INJECTION 20 MG/MLSANOFI-AVENTIS CANADA INCSolutionDOLASETRON MESYLATE 20 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
79312006-05-04New Drug Submission (NDS)MANUFACTURER NAME CHANGE
11052000-06-16New Drug Submission (NDS)
37311997-05-21New Drug Submission (NDS)

International API supply for DOLASETRON MESYLATE

2 active FDA Drug Master Files.

Request a quote for ANZEMET

How to read a Canadian DIN record